Eli Lilly and Company (LLYCL)
Summary
LLYCL Chart
LLY Stock Too Cheap At $750?
Question: Why would you pay 81 times earnings for AbbVie stock when you can buy LLY for a similar valuation of 76 times earnings? You wouldn't, especially when you consider three simple facts:
Eli Lilly : A Breakout Biotech Powerhouse With Room to Run
Eli Lilly NYSE: LLY has transformed from a steady pharmaceutical giant into one of Wall Street's standout growth stories—and it's not just hype. Powered by blockbuster drugs for diabetes and weight loss, a deep pipeline of next-generation treatments, and aggressive investment in future capacity, Lilly is rewriting what long-term success looks like in Big Pharma.
Novo Nordisk's weight-loss drug Wegovy has been surpassed in weekly U.S. prescriptions by Eli Lilly's Zepbound, and now the company is trying to get back on track
Novo Nordisk's weight-loss drug Wegovy has been surpassed in weekly U.S. prescriptions by Eli Lilly's Zepbound, and now the company is trying to get back on track.
Eli Lilly and Company Dividends
 LLY 2 weeks ago Announced | Quarterly | $1.5 Per Share |
| LLY 3 months ago Paid | Quarterly | $1.5 Per Share |
| LLY 6 months ago Paid | Quarterly | $1.3 Per Share |
| LLY 9 months ago Paid | Quarterly | $1.3 Per Share |
| LLY 15 May 2024 Paid | Quarterly | $1.3 Per Share |
Eli Lilly and Company Earnings
| 28 Apr 2025 Date | | - Cons. EPS | - EPS |
| 6 Feb 2025 Date | | 5.07 Cons. EPS | 5.32 EPS |
| 4 Feb 2025 Date | | - Cons. EPS | - EPS |
| 30 Oct 2024 Date | | 1.47 Cons. EPS | 1.18 EPS |
| 8 Aug 2024 Date | | 2.6 Cons. EPS | 3.92 EPS |
| LLY 2 weeks ago Announced | Quarterly | $1.5 Per Share |
| LLY 3 months ago Paid | Quarterly | $1.5 Per Share |
| LLY 6 months ago Paid | Quarterly | $1.3 Per Share |
| LLY 9 months ago Paid | Quarterly | $1.3 Per Share |
| LLY 15 May 2024 Paid | Quarterly | $1.3 Per Share |
| 28 Apr 2025 Date | | - Cons. EPS | - EPS |
| 6 Feb 2025 Date | | 5.07 Cons. EPS | 5.32 EPS |
| 4 Feb 2025 Date | | - Cons. EPS | - EPS |
| 30 Oct 2024 Date | | 1.47 Cons. EPS | 1.18 EPS |
| 8 Aug 2024 Date | | 2.6 Cons. EPS | 3.92 EPS |
Eli Lilly and Company (LLYCL) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Eli Lilly and Company ever had a stock split?
Eli Lilly and Company Profile
| Drug Manufacturers - General Industry | Healthcare Sector | Mr. David A. Ricks CEO | XSGO Exchange | US5324571083 ISIN |
| US Country | 47,000 Employees | 14 Feb 2025 Last Dividend | 16 Oct 1997 Last Split | 13 Jan 1978 IPO Date |
Overview
Eli Lilly and Company is a global leader in the discovery, development, and marketing of human pharmaceuticals. With a history dating back to 1876, the company has established itself as a key player in the pharmaceutical industry, offering a wide range of products aimed at treating a variety of conditions. Headquartered in Indianapolis, Indiana, Eli Lilly and Company has forged multiple collaborations with other pharmaceutical giants such as Incyte Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, Genentech, Inc., Biologics, Inc., AbCellera Biologics Inc., and Chugai Pharmaceutical Co., Ltd., enhancing its product offerings and research capabilities across different therapeutic areas.
Products and Services
- Diabetes Care
Includes a comprehensive portfolio of insulin and other diabetes treatments: Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500. Additionally, the company offers Jardiance, Mounjaro, and Trulicity for managing type 2 diabetes.
- Oncology
Provides a range of products for cancer treatment, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio, focusing on different types of cancer and treatment approaches.
- Immunology
Olumiant is offered for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19. Taltz is available for treating plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis.
- Digestive Diseases
Omvoh is targeted at ulcerative colitis, reflecting the company's commitment to addressing gastrointestinal disorders.
- Neurological Disorders
Includes Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain. Emgality is provided for migraine prevention and treatment of episodic cluster headache.
- Other Therapeutic Areas
The company also offers Cialis for erectile dysfunction and benign prostatic hyperplasia; Forteo for osteoporosis treatment; Zepbound for obesity management; and Ebglyss for severe atopic dermatitis, showcasing Eli Lilly's diverse portfolio catering to various health conditions.
Contact Information
